Health Care/Hospital

Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC

SUZHOU, China and ROCKVILLE, Md., Oct. 23, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest clinical data of it...

2023-10-23 19:56 1097

Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs

SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces the latest clinical progress of 2 novel drugs including Nectin-4 ADC 9MW2821, as well as the clinical study data to be reported on ESMO 2023. Latest progress...

2023-10-23 18:25 1205

JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval

HONGKONG, SHANGHAI, and BEIJING, Oct. 23, 2023 /PRNewswire/ -- As the first hearing aid manufacturer to be listed in China, JINGHAO MEDICAL has once again taken a historic step. OnSeptember 26, 2023, the self-fitting OTC hearing aid developed and manufactured by JINGHAO MEDICAL officially receive...

2023-10-23 18:01 1112

Global Healthcare Accreditation Welcomes Karin Jay as President of Global Strategy and Announces Renée-Marie Stephano's Transition to CEO

New Leadership Aims to Reinforce GHA's Position as the Foremost Authority in Medical and Well-being Travel Accreditation PALM BEACH GARDENS, Fla., Oct. 23, 2023 /PRNewswire/ -- Global Healthcare Accreditation (GHA), the esteemed authority in accreditation and certification with a specialized foc...

2023-10-23 18:00 1416

Sunvozertinib Demonstrates Best-in-Class Potential as a First-Line Treatment for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer Patients

* Sunvozertinib monotherapy demonstrated superior efficacy and excellent safety in patients in the 1st line setting for advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutations, achieving a confirmed objective...

2023-10-23 17:34 993

InxMed Releases Data Demonstrating Ifebemtinib (IN10018) Trending Toward Survival Benefit at ESMO 2023

NANJING, China, Oct 22, 2023 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome drug resistance for hard-to-treat solid tumors, announces that clinical data of Ifebemtinib (IN10018), a highly potent and selective oral i...

2023-10-23 08:00 1372

Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO

* The ORR (objective response rate) and the DCR (disease control rate) in the frontline setting of glecirasib (KRAS G12C Inhibitor) in combination with JAB-3312 (SHP2 inhibitor) were 65.5% (38/58) and 100% respectively in all dose groups of advanced non-small cell lung cancer (NSCLC), among whi...

2023-10-22 15:05 1718

Zhimeng Biopharma CB03 Received Orphan Drug Designation from the US FDA - A Potassium Ion Channel Opener for Amyotrophic Lateral Sclerosis

SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced that one of its innovative small-molecule KCNQ2/3 selective opener compounds (CB03), developed for the treatment of amyotrophic lateral sclerosis (ALS), received orphan drug designation (ODD) from US F...

2023-10-20 21:00 997

The 14th China (Taizhou) International Medical Expo Opens, Empowering the Growth of the Healthcare Industry

TAIZHOU, China, Oct. 20, 2023 /PRNewswire/ -- On October 19, the 14th China (Taizhou) International Medical Expo commenced at the China Medical City Convention Trade Center. Themed "Innovation Empowers the Construction of a Large Health Industry Ecosystem", this edition of the Medical Expo gather...

2023-10-20 17:17 1699

WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards

SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract, Resea­­rch, Development, and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, announced it has been named thewinner of the "Best Contract Development Manufacturing Organization (CDMO...

2023-10-20 16:00 1212

GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023

- An innovative study of methylation markers and deep learning model enables precise lung cancer diagnosis. YONGIN, South Korea, Oct. 20, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present data showcasing deep learning algorithm utiliz...

2023-10-20 13:10 1120

NATIONAL UNIVERSITY HOSPITAL LAUNCHES GLOBAL FELLOWS ALLIANCE TO FOSTER INTERNATIONAL HEALTHCARE COLLABORATION

Fellows trained in NUH have emerged as leaders who are catalysing change in their respective fields upon their return home SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- In line with its mission of being Singapore's leading university hospital, the National University Hospital (NUH) is launching its h...

2023-10-19 21:57 1647

NUS scientists develop innovative magnetic gel that heals diabetic wounds three times faster

First-of-its-kind cell therapy promotes wound healing, improves overall wound health and lowers risks of recurrence SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-h...

2023-10-19 20:01 1221

World's first expo on health and healing! 2023 Sancheong World Traditional Medicine Anti-aging Expo ends with great success

- The world's first festival on health and healing, featuring a variety of content - Opportunity to enhance the competitiveness of K-anti-aging industry and show the excellence of traditional Korean medicine to the world GYEONGNAM, South Korea, Oct. 19, 2023 /PRNewswire/ -- The 2023 Sancheong W...

2023-10-19 20:00 1299

Phase 1a/1b Study Results of Akeso's PD-1/CTLA-4 Bispecific Antibody Published in Cell Reports Medicine, Highlighting Promising Efficacy in Solid Tumors Refractory/Relapsed to Standard Therapy

HONG KONG, Oct. 19, 2023 /PRNewswire/ -- Akeso (9926. HK) announced the publication of the phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab (PD-1/CTLA-4 bispecific antibody) in patients with advanced solid tumors in Cell Reports Medicine, a sub-publication of Cell. Full ar...

2023-10-19 20:00 1199

InxMed Presents New Data at 14th Annual World ADC Highlighting Synergy of IN10018 with ADCs and Novel Stroma targeting pipeline

NANJING, China, Oct. 18, 2023 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome treatment resistance for hard-to-treat solid tumors, is presenting preclinical data at 14th Annual World ADC Conference in San Diego regar...

2023-10-19 08:00 1282

Zepp Health Sponsors Cal Hacks 10.0, the World's Largest Collegiate Hackathon, for the Second Consecutive Year

- Winners with the best apps will receive Zepp's Amazfit smartwatches and cash award MILPITAS, Calif., Oct. 18, 2023 /PRNewswire/ -- Zepp Health Corporation, a global leader in smart wearables and health technology, is excited to announce its sponsorship of Cal Hacks, the world's largest collegi...

2023-10-19 03:04 1434

ITRI Excels with Eight 2023 R&D 100 Awards, Showcasing Biotechnological Triumph

HSINCHU, Oct. 18, 2023 /PRNewswire/ -- In the recent announcement of the 2023 R&D 100 Awards,ITRI , Taiwan's largest and one of the world's leading high-tech applied research institutions, has clinched eight 2023 R&D 100 Awards, the second-highest number of awards by a s...

2023-10-19 01:10 1570

CJ Foods Partners with T&R Biofab to Shape the Future of Food

CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agre...

2023-10-18 21:00 1583

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

* With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry * Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities * Shortlisted as a finalist for ...

2023-10-18 20:00 1155
1 ... 25262728293031 ... 252

Week's Top Stories